PDS Biotechnology
PDSB
PDSB
77 hedge funds and large institutions have $42M invested in PDS Biotechnology in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 78 → 77 (-1)
55% less call options, than puts
Call options by funds: $1.04M | Put options by funds: $2.31M
Holders
77
Holding in Top 10
–
Calls
$1.04M
Puts
$2.31M
Top Buyers
| 1 | +$1.99M | |
| 2 | +$600K | |
| 3 | +$504K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$401K |
| 5 |
BlackRock
New York
|
+$388K |
Top Sellers
| 1 | -$707K | |
| 2 | -$513K | |
| 3 | -$433K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$347K |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$131K |